Tech Company Financing Transactions
Akeso Biomedical Funding Round
Akeso Biomedical closed a $4.4 million funding round on 6/14/2017. Backers included private investors.
Transaction Overview
Company Name
Announced On
6/14/2017
Transaction Type
Venture Equity
Amount
$4,400,000
Round
Undisclosed
Investors
Proceeds Purpose
Akeso will use some of the funds to develop manufacturing and global distribution partnerships for TYPLEX Chelate, a zootechnical gut health stabilizer which inhibits pathogenic bacteria, such as Clostridium, Campylobacter, Salmonella and E. coli from adhering to avian gut walls.
Company Information
Company Status
Private & Independent
Industry
AgTech
Mailing Address
2400 District Ave.
Burlington, MA 01803
USA
Burlington, MA 01803
USA
Phone
Website
Email Address
Overview
Akeso Biomedical is a food safety company developing new solutions for the treatment of bacterial infections using a broad-spectrum iron complex chemistry discovered by researchers at the University of Nottingham, UK.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Gregory Lee
Chief Executive Officer
Simon Williams
Chief Operating Officer
Jerome Meier
Browse more venture capital transactions:
Prev: 6/14/2017: Fusion Risk Management venture capital transaction
Next: 6/14/2017: LabConnect venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs